What is the optimal distal resection margin for esophageal carcinoma?

Slides:

Advertisements

Similar presentations

Aortic Valve Replacement With Patch Enlargement of the Aortic Annulus

Advertisements

Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L

Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes Meng S. Shao, MD, Andrew T. Wong, MD,

Preoperative Serum Fibrinogen Level Predicts Postoperative Pulmonary Complications After Lung Cancer Resection Suk-Won Song, MD, Hyun-Sung Lee, MD, Moon.

Ratio of Metastatic Lymph Nodes to Total Number of Nodes Resected is Prognostic for Survival in Esophageal Carcinoma Clive J. Kelty, MB, ChB, PhD, FRCSEd,

Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F

Cytologically malignant margins of wedge resected stage I non-small cell lung cancer Noriyoshi Sawabata, MD, Akihide Matsumura, MD, Mitsunori Ohota, MD,

Value of radiotherapy after radical surgery for esophageal carcinoma: a report of 495 patients Ze Fen Xiao, MD, Zong Yi Yang, MD, Jun Liang, MD, Yan.

Jan G Grandjean, MD, PhD, Marco Lucchi, MD, Massimo A Mariani, MD, PhD

Sarcomatoid Carcinoma of the Lung: A Predictor of Poor Prognosis

Emergent Esophagectomy for Esophageal Perforations: A Safe Option

Percutaneous endoscopic gastrostomy before multimodality therapy in patients with esophageal cancer Marc Margolis, MD, Pendleton Alexander, MD, Gregory.

Prognostic Factors Associated With Interventional Bronchoscopy in Lung Cancer Nicolas Guibert, MD, Julien Mazieres, MD, PhD, Benoît Lepage, MD, Gavin.

Periodic pharyngolaryngoscopy detects early head and neck cancer and improves survival in esophageal cancer Akihito Watanabe, MD, Masao Hosokawa, MD,

Prognostic Value of Different Lymph Node Staging Methods in Esophageal Squamous Cell Carcinoma After Esophagectomy San-Gang Wu, MD, Feng-Yan Li, MD,

Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases

Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: the Japanese experience Tsuguo Naruke,

Esophageal Resection for Cancer of the Esophagus: Long-Term Function and Quality of Life Allison J McLarty, MD, Claude Deschamps, MD, Victor F Trastek,

Non-Small Cell Lung Cancer Resection in Lymphoma Patients

Tumors of the esophagogastric junction

Michelle C. Ellis, MD, Brian S. Diggs, PhD, John T. Vetto, MD, Paul H

Factors predicting patterns of recurrence after resection of N1 non-small cell lung carcinoma Timothy E Sawyer, MD, James A Bonner, MD, Perry M Gould,

Andrea S. Wolf, MD, MPH, Scott J

Combined Resection of Superior Vena Cava for Lung Carcinoma: Prognostic Significance of Patterns of Superior Vena Cava Invasion Kenji Suzuki, MD, Hisao.

Sex-associated differences in survival of patients undergoing resection for lung cancer Mark K Ferguson, MD, Jun Wang, MD, Philip C Hoffman, MD, Daniel.

Iwao Takanami, MD, Ken Takeuchi, MD, Masatoshi Giga, MD

Surgical Resection of Rare Esophageal Cancers

Clinicopathologic Features of Resected Subcentimeter Lung Cancer

Clinicopathologic and Prognostic Implications of Programmed Death Ligand 1 Expression in Thymoma Shintaro Yokoyama, MD, Hiroaki Miyoshi, MD, PhD, Tatsuya.

Repke J Snijder, Aart Brutel de la Rivière, Hans J. J Elbers, Jules M

Bilobectomy for Lung Cancer: Analysis of Indications, Postoperative Results, and Long- Term Outcomes Domenico Galetta, MD, PhD, Piergiorgio Solli, MD,

Radical Lymph Node Dissection in Primary Esophagectomy for Esophageal Squamous Cell Carcinoma Chen-Sung Lin, MD, PhD, Chih-Tao Cheng, MD, DrPH, Chao-Yu.

Thymic carcinoma outcomes and prognosis: Results of an international analysis Usman Ahmad, MD, Xiaopan Yao, PhD, Frank Detterbeck, MD, James Huang, MD,

Outcomes After Extrapleural Pneumonectomy and Intensity-Modulated Radiation Therapy for Malignant Pleural Mesothelioma David C. Rice, MB, BCh, Craig.

Comparison of the 6th and 7th Editions of the American Joint Committee on Cancer Tumor-Node-Metastasis Staging System in Patients With Resected Esophageal.

Recurrence and Survival After Segmentectomy in Patients With Prior Lung Resection for Early-Stage Non-Small Cell Lung Cancer Lisa M. Brown, MD, Brian.

The Prognostic Value of the Number of Negative Lymph Nodes in Esophageal Cancer Patients After Transthoracic Resection Po-Kuei Hsu, MD, Chien-Sheng Huang,

Survival After Surgical Resection of Stage IV Esophageal Cancer

Is There a Role for Cancer-Directed Surgery in Early-Stage Sarcomatoid or Biphasic Mesothelioma? Samuel Kim, MD, David A. Bull, MD, Linda Garland, MD,

Impact of positive pleural lavage cytology on survival in patients having lung resection for non–small-cell lung cancer: An international individual patient.

Prolonged Overall Survival After Pulmonary Metastasectomy in Patients With Breast Cancer Georgios Meimarakis, MD, Dominik Rüttinger, MD, PhD, Joachim.

Predictors of Long-Term Survival After Resection of Esophageal Carcinoma With Nonregional Nodal Metastases Paul C. Lee, MD, Jeffrey L. Port, MD, Subroto.

Primary Cardiac Sarcoma

Valerie W Rusch, MD, Ennapadam S Venkatraman, PhD

Evolving management and outcome of esophageal cancer with airway involvement E.Pendleton Alexander, MD, Gregory D Trachiotis, MD, Timothy O Lipman, MD,

Pulmonary Resection for Lung Cancer in Octogenarians

High Expression of p300 Has an Unfavorable Impact on Survival in Resectable Esophageal Squamous Cell Carcinoma Yong Li, MD, Hao-Xian Yang, MD, Rong-Zhen.

Clinicopathologic Features of Submucosal Esophageal Squamous Cell Carcinoma Manabu Emi, MD, PhD, Jun Hihara, MD, PhD, Yoichi Hamai, MD, PhD, Takaoki Furukawa,

Clinicopathologic Features and Computed Tomographic Findings of 52 Surgically Resected Adenosquamous Carcinomas of the Lung Yukio Watanabe, MD, Koji.

Editorial Board, January 2010

Number of Metastatic Lymph Nodes in Resected Non–Small Cell Lung Cancer Predicts Patient Survival Jin Gu Lee, MD, Chang Young Lee, MD, In Kyu Park, MD,

Comparison of Neoadjuvant Chemotherapy Followed by Surgery to Upfront Surgery for Thymic Malignancy Samina Park, MD, In Kyu Park, MD, PhD, Young Tae.

Carcinoma of the esophagus: Prognostic significance of histologic type

Risk Factors for Local Recurrence and Optimal Length of Esophagectomy in Esophageal Squamous Cell Carcinoma Chang Hyun Kang, MD, PhD, Yoohwa Hwang, MD,

Predictors of Survival After Operation Among Patients With Large Cell Neuroendocrine Carcinoma of the Lung Florian Eichhorn, MD, Hendrik Dienemann, MD,

Is there a role for pneumonectomy in pulmonary metastases?1

Prognosis of Patients With Pathologic T0 N+ Esophageal Squamous Cell Carcinoma After Chemoradiotherapy and Surgical Resection: Results From a Nationwide.

Edwin van Velzen, MD, Aart Brutel de la Rivière, MD, PhD, Hans J

Resected Synchronous Primary Malignant Lung Tumors: A Population-Based Study Hans Rostad, MD, PhD, Trond-Eirik Strand, MD, Anne Naalsund, MD, Jarle Norstein,

Sebastien Gilbert, MD, Andre B. Martel, BSc, Andrew J

Neoadjuvant Chemoradiation Therapy Is Beneficial for Clinical Stage T2 N0 Esophageal Cancer Patients Due to Inaccurate Preoperative Staging Jennifer.

Neoadjuvant and Adjuvant Chemotherapy in Resected Pulmonary Large Cell Neuroendocrine Carcinomas: A Single Institution Experience Inderpal S. Sarkaria,

Neal S Goldstein, MD The Annals of Thoracic Surgery

Pneumonectomy After Chemoradiation Therapy for Non-Small Cell Lung Cancer: Does “Side” Really Matter? Anthony W. Kim, MD, L. Penfield Faber, MD, William.

Tracheoplasty in a large tracheoesophageal fistula

Survival and Outcomes of Pulmonary Resection for Non-Small Cell Lung Cancer in the Elderly: A Nested Case-Control Study Robert J. Cerfolio, MD, Ayesha.

Minimally invasive resection of mediastinal parathyroid adenomas

Low-dose oral amiodarone prophylaxis reduces atrial fibrillation after pulmonary resection Louis A Lanza, MD, Antonio I Visbal, MD, Patrick A DeValeria,

Mark I. Block, MD The Annals of Thoracic Surgery

Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD

Presentation transcript:

What is the optimal distal resection margin for esophageal carcinoma? Alan G Casson, S.Jane Darnton, PhD, Sujata Subramanian, Louise Hiller, BSc The Annals of Thoracic Surgery Volume 69, Issue 1, Pages 205-209 (January 2000) DOI: 10.1016/S0003-4975(99)01262-X

Fig 1 (A) Overall survival for all patients. (B) Overall survival for all patients by stage. From top to bottom, stage I (upper solid black line); stage IIA/B (upper short broken line); stage III (alternating dash/dots); stage IV (lower long broken line). The Annals of Thoracic Surgery 2000 69, 205-209DOI: (10.1016/S0003-4975(99)01262-X)

Fig 2 Overall survival for all patients by distal resection margin status. Patients with histologically positive distal resection margins (n = 24; solid line) had a trend toward reduced survival (p = 0.17, not significant) compared to patients with negative margins (n = 165; broken line). The Annals of Thoracic Surgery 2000 69, 205-209DOI: (10.1016/S0003-4975(99)01262-X)